Silence Therapeutics (SLN) Amortizatization of Intangibles (2024 - 2026)
Silence Therapeutics' (SLN) quarterly Amortizatization of Intangibles came in at $34000.0 in Q1 2026, down 47.69% year-on-year from $65000.0 in Q1 2025, and down 5.56% quarter-over-quarter from $36000.0 in Q4 2025.
Silence Therapeutics (SLN) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Silence Therapeutics has disclosed Amortizatization of Intangibles across 3 years of filings, most recently posting $34000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $34000.0, down 47.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $212000.0 (down 17.83% YoY), and the FY2025 annual result was $243000.0, down 5.45% from the prior year.
- Amortizatization of Intangibles came in at $34000.0 for Q1 2026 at Silence Therapeutics, down from $36000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $75000.0 in Q3 2025 to a low of $34000.0 in Q1 2026.
- The 3-year median for Amortizatization of Intangibles is $64000.0 (2024), against an average of $59333.3.
- Across the five-year window, Amortizatization of Intangibles increased 15.38% in 2025 and tumbled 47.69% in 2026, its largest moves.
- Silence Therapeutics' Amortizatization of Intangibles stood at $64000.0 in 2024, then sank by 43.75% to $36000.0 in 2025, then decreased by 5.56% to $34000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $34000.0 (Q1 2026), $36000.0 (Q4 2025), and $75000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Silence Therapeutics | 966.41 Mn | 896.33 Mn | 411,000.00 | 34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | 67,000.00 |
| Jun 30, 2025 | 67,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | 65,000.00 |
| Sep 30, 2024 | 65,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Mar 31, 2024 | 64,000.00 |